Category: Financial assistance

The list price for a single 150 mg vial of ILARIS can exceed $20,000, making it one of the most expensive specialty medications on the market. For most patients, however, the actual out-of-pocket **what is the price of ILARIS 150 mg** is significantly lower due to insurance coverage and comprehensive financial assistance programs offered by the manufacturer and non-profit organizations.

The monthly retail cost of Verzenio without insurance can exceed $8,000, placing a significant financial burden on patients. This makes understanding how to get Verzenio cheaper a crucial part of a comprehensive treatment plan for many patients managing their breast cancer expenses.

The list price for a 30-day supply of Biktarvy can exceed $4,000, but most patients do not pay this amount. Your actual out-of-pocket expense for a 30-day supply of Biktarvy depends heavily on your insurance status, eligibility for manufacturer coupons, and participation in patient assistance programs.

The average retail price for a one-month supply of Eliquis (apixaban) can exceed $550, making its high cost a significant barrier for many patients. When faced with this financial hardship, it's crucial to understand your options and ask, "What can I take if I can't afford Eliquis?".

A single 4 mg vial of Zepzelca has a list price of around $8,066.50 in the US, but the total treatment cost depends on several factors. Navigating the expense of this medication, particularly when considering the question of how much is Zepzelca in the US, requires a deep understanding of the variables that influence pricing.